Press release
Cancer Pain Market – Global Market Opportunity Assessment Study 2017-2025
Cancer pain can be categorized as acute and chronic based on the onset and duration of cancer. Acute cancer pains have an identifiable cause, well-defined onset, are subject to sympathetic output and improve with management. Acute cancer pain syndromes are caused by antineoplastic therapies such as chemotherapy, hormonal treatments, immunotherapy, and radiation therapy; procedures such as post-biopsy pain, stent placements, vascular embolization, and paracentesis, among others. Chronic cancer pain has a prolonged, and the fluctuating course has a less distinct onset and is driven by central sensitization and neuroplastic responses from acute injury. Chronic cancer pain syndromes are caused by somatic nociceptive pain due to soft tissue involvement, and bone metastases; and neuropathic pain due to malignancy.
Request for Report TOC @ https://www.persistencemarketresearch.com/toc/13528
Cancer pain market can be segmented based on the drug class used for the pain management, by device type, by the end user, and geography. By drug class, cancer pain market has been segmented into opioids, Non-steroidal anti-inflammatory drugs (NSAIDs), corticosteroids, Antidepressants and anticonvulsants, Bisphosphonates, and Ketamine, among others. By device type, cancer pain market can be segmented into implantable intrathecal drug delivery system and programmable intrathecal drug delivery system. Cancer pain market has been segmented into hospitals, cancer research institutes, clinics, and ambulatory surgical centers, among others by end users. By geography, Cancer pain market has been classified into North America, Latin America, Europe, Asia-Pacific, and the Middle East & Africa.
According to National Cancer Institute, over 1,660,290 new patients were diagnosed with cancer and over 580,350 Americans died of cancer in 2013. Pain is one of the most dreaded symptoms in cancer, and it is moderate to severe in more than 50% of cancer patients. A similar increase in the number of cancer patients has been noted globally, which is one of the major growth drivers of cancer pain management. Globally, over 75% of the cancer patients complain of a gradual increase in pain as the disease progresses, and chronic pain is experienced by nearly 70% of the patients suffering from spinal cord injuries, 8% of stroke patients, and 28% of multiple sclerosis patients. This increase in the number of cancer patients experiencing pain will have a positive effect on the growth of cancer pain market. Also, a range of cancer pain management drugs is in the pipeline, indicating the increased research and development that would lead to the growth of the cancer pain market. Furthermore, increased healthcare spending and the availability of reimbursement would aid in the growth of the cancer pain market. However, lack of awareness and the high cost of treatment might hamper the cancer pain market.
Opioids are expected to remain the dominant drug class segment in cancer pain market, owing to their ability to effectively treat the cancer pain. Geographically, North America is expected to lead the cancer pain market. The presence of market leaders in the region, well-developed healthcare infrastructure, and enhanced healthcare spending contribute to the growth of the cancer pain market in the region. However, Asia Pacific is expected to record a high CAGR growth in the cancer pain market during the forecast period, owing to the growing awareness among people, and increased government spending on providing enhanced healthcare services to the people. China, Brazil, and India are expected to drive strong growth in the cancer pain market as a result of increasing investments by the government to enhance the healthcare facilities.
Request for Report Sample @ https://www.persistencemarketresearch.com/samples/13528
The leading players in the cancer pain market include Pfizer, Inc., Purdue Pharma, Mallinckrodt Pharmaceuticals, Teva Pharmaceuticals, Eli Lilly and Company, Johnson & Johnson, Endo Pharmaceuticals Inc., BioDelivery Sciences, ProStrakan Group, Sanofi S.A., and Grunenthal Group, among other significant global market players.
About Us
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMR’s collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.
Contact Us
Persistence Market Research
305 Broadway,7th Floor
New York City, NY 10007
United States
Tel: +1-646-568-7751
Tollfree: +1 800-961-0353
Email: sales@persistencemarketresearch.com
Website: https://www.persistencemarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cancer Pain Market – Global Market Opportunity Assessment Study 2017-2025 here
News-ID: 806343 • Views: …
More Releases from Persistence Market Research
Music Tourism Market Analysis Highlights 5.5% CAGR Through 2032
The global music tourism market is set to witness consistent growth over the next decade, supported by the rising popularity of live music experiences and experiential travel. According to recent industry analysis, the global music tourism market size is likely to be valued at US$9.6 billion in 2025 and is projected to reach US$14.0 billion by 2032, expanding at a compound annual growth rate (CAGR) of 5.5% during the forecast…
Electronic Dance Music Market Analysis Highlights Robust Growth Through 2031
➤ Introduction
The global Electronic Dance Music (EDM) market has emerged as one of the most dynamic and influential segments within the broader music and entertainment industry. Characterized by high-energy beats, immersive live performances, and strong digital integration, EDM has evolved from an underground cultural movement into a mainstream global phenomenon. The genre's rapid adoption across music festivals, nightclubs, streaming platforms, and social media channels has significantly reshaped consumer listening habits…
Global Memory Market Set for Strong Growth Driven by AI and Data Centers
The global memory market is entering one of its most transformative growth cycles in decades. As digital ecosystems scale rapidly across artificial intelligence (AI), cloud computing, data centers, automotive electronics, and edge devices, memory technologies are becoming the backbone of modern computing infrastructure. From high-performance servers to connected vehicles and IoT endpoints, memory capacity, speed, and efficiency now directly influence system performance and competitiveness.
The global memory market size is likely…
Why Network Traffic Analyzers Are Becoming Critical for Modern Enterprises
The global digital ecosystem is undergoing an unprecedented transformation as enterprises, governments, and service providers become increasingly dependent on high-performance, always-on networks. In this environment, understanding how data flows across networks is no longer optional-it is mission-critical. Network traffic analyzers have emerged as essential tools that enable organizations to monitor, inspect, and optimize network performance while defending against escalating cyber risks.
The global network traffic analyzer market is likely to be…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
